Steve Parsons-WPA Pool/Getty Images AstraZeneca and the University of Oxford are facing criticism over their COVID-19 vaccine trial results after acknowledging a mistake in the vaccine dosage. During the trial, some patients got two full doses of the vaccine, while others had a half-dose in their first shot followed by a full dose in the second. An AstraZeneca executive, Dr.